Cargando…
Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
BACKGROUND: As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine. MA...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135374/ https://www.ncbi.nlm.nih.gov/pubmed/34035647 http://dx.doi.org/10.1186/s42269-021-00550-w |
_version_ | 1783695338976051200 |
---|---|
author | Aouissi, Hani Amir Ababsa, Mostefa Gaagai, Aissam |
author_facet | Aouissi, Hani Amir Ababsa, Mostefa Gaagai, Aissam |
author_sort | Aouissi, Hani Amir |
collection | PubMed |
description | BACKGROUND: As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine. MAIN BODY: The aim of this review was to synthesize the different highlights of the most important studies published since the beginning of the epidemic crisis. After a precise study of the available bibliography dealing with this subject and the addition of an adapted example, which is the current situation of Algeria, the results showed the effectiveness of the Algerian method as well as the impact that this treatment had. CONCLUSION: We concluded that in brief, given the inexistence of a better solution, we ultimately recommend that patients with severe COVID-19 to be treated for the moment with Hydroxychloroquine combined with Azithromycin in view of its effectiveness, while waiting for another solution. |
format | Online Article Text |
id | pubmed-8135374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81353742021-05-21 Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria Aouissi, Hani Amir Ababsa, Mostefa Gaagai, Aissam Bull Natl Res Cent Review BACKGROUND: As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine. MAIN BODY: The aim of this review was to synthesize the different highlights of the most important studies published since the beginning of the epidemic crisis. After a precise study of the available bibliography dealing with this subject and the addition of an adapted example, which is the current situation of Algeria, the results showed the effectiveness of the Algerian method as well as the impact that this treatment had. CONCLUSION: We concluded that in brief, given the inexistence of a better solution, we ultimately recommend that patients with severe COVID-19 to be treated for the moment with Hydroxychloroquine combined with Azithromycin in view of its effectiveness, while waiting for another solution. Springer Berlin Heidelberg 2021-05-20 2021 /pmc/articles/PMC8135374/ /pubmed/34035647 http://dx.doi.org/10.1186/s42269-021-00550-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Aouissi, Hani Amir Ababsa, Mostefa Gaagai, Aissam Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria |
title | Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria |
title_full | Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria |
title_fullStr | Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria |
title_full_unstemmed | Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria |
title_short | Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria |
title_sort | review of a controversial treatment method in the fight against covid-19 with the example of algeria |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135374/ https://www.ncbi.nlm.nih.gov/pubmed/34035647 http://dx.doi.org/10.1186/s42269-021-00550-w |
work_keys_str_mv | AT aouissihaniamir reviewofacontroversialtreatmentmethodinthefightagainstcovid19withtheexampleofalgeria AT ababsamostefa reviewofacontroversialtreatmentmethodinthefightagainstcovid19withtheexampleofalgeria AT gaagaiaissam reviewofacontroversialtreatmentmethodinthefightagainstcovid19withtheexampleofalgeria |